Gilead Sciences, Inc. (GILD) Shares Bought by Davidson Investment Advisors

Lloyd Doyle
January 23, 2018

The stock has "Buy" rating by Deutsche Bank on Monday, August 7. Kempner Capital Management Inc. now owns 66,890 shares of the biopharmaceutical company's stock worth $4,734,000 after buying an additional 2,428 shares in the last quarter. Blue Edge Capital Llc who had been investing in General Electric Co for a number of months, seems to be bullish on the $140.23B market cap company. The stock decreased 0.35% or $0.88 during the last trading session, reaching $247.3. About 1.86M shares traded or 4.92% up from the average. (NYSE:AIG) has risen 8.59% since January 23, 2017 and is uptrending. It has underperformed by 11.26% the S&P500.

Contrarius Investment Management Ltd decreased Gilead Sciences Inc (GILD) stake by 25.52% reported in 2017Q3 SEC filing. Evergreen Capital Management Llc bought 6,280 shares as the company's stock declined 8.05% while stock markets rallied. Gilead Sciences, Inc. The firm has a market cap of $106,320.00, a P/E ratio of 9.26, a price-to-earnings-growth ratio of -1.76 and a beta of 1.13.

The Company ended its previous trading session at $81.12 with the gain of 1.12%.

Hourglass Capital Llc, which manages about $861.92 million and $420.07 million US Long portfolio, upped its stake in Alphabet Inc by 1,155 shares to 6,010 shares, valued at $5.85M in 2017Q3, according to the filing.

Gilead Sciences, Inc. (NASDAQ:GILD) is another stock that is grabbing investors attention these days. It has underperformed by 16.70% the S&P500. MARTIN JOHN C sold $6.09 million worth of Gilead Sciences, Inc. Also, EVP James R. Meyers sold 100,000 shares of the company's stock in a transaction on Tuesday, January 16th. In the last quarter, insiders sold 591,666 shares of company stock worth $44,466,567. Howland Capital Mgmt Ltd Liability Corporation reported 1.72% stake.

Among 19 analysts covering CIGNA (NYSE:CI), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 63% are positive. The firm earned "Overweight" rating on Thursday, November 5 by Piper Jaffray. The stock now has an average rating of "Buy" and an average price target of $85.53. Jefferies Group restated a "hold" rating and issued a $93.00 target price on shares of Gilead Sciences in a research note on Wednesday, October 4th. The rating was downgraded by Argus Research on Friday, July 29 to "Hold". As per Friday, October 27, the company rating was maintained by BMO Capital Markets. On Tuesday, May 30 the stock rating was maintained by Cowen & Co with "Buy". The rating was maintained by M Partners with "Buy" on Tuesday, August 11.

It tells an investor how quickly a company is increasing its revenues. Its up 0.10, from 0.93 in 2017Q2. It fall, as 59 investors sold MMM shares while 612 reduced holdings.

VANGUARD GROUP INC raised its stake in Gilead Sciences, Inc. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Moreover, First Foundation Advsr has 0.43% invested in Gilead Sciences, Inc. Zacks Investment Research downgraded Gilead Sciences from a "hold" rating to a "sell" rating in a research report on Thursday, January 18th. (NASDAQ:GILD) by 194.2% in the 3rd quarter, according to the company in its most recent disclosure with the SEC.

Zwj Investment Counsel Inc increased Johnson Ctls Intl Plc stake by 41,021 shares to 468,801 valued at $18.89 million in 2017Q3.

ILLEGAL ACTIVITY NOTICE: "Sector Gamma AS Has $27.20 Million Position in Gilead Sciences, Inc". (NASDAQ:GILD) for 84,522 shares. Lord Abbett And Communications Limited Co stated it has 62,400 shares. (NASDAQ:GILD) for 8,130 shares. Horizon Kinetics Ltd Limited Liability Company holds 0.06% or 81,731 shares. Bank Of Stockton bought 2,363 shares as the company's stock rose 11.09% with the market. Natl Insur Tx holds 0.82% of its portfolio in Gilead Sciences, Inc. The company has its outstanding shares of 1.31 Billion. Ig Invest Mgmt Limited owns 0.16% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Capital Guardian stated it has 74,502 shares. Harel Insurance Investments & Financial Services Ltd. now owns 2,120 shares of the biopharmaceutical company's stock valued at $150,000 after buying an additional 480 shares during the period. Sns Fincl Group Ltd holds 26,045 shares. Balyasny Asset Mngmt Lc holds 0.06% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 98,250 shares. It also increased its holding in Hospitality Pptys Tr (NYSE:HPT) by 18,200 shares in the quarter, for a total of 349,085 shares, and has risen its stake in Scorpio Bulkers Inc.

Since August 8, 2017, it had 2 insider buys, and 1 sale for $4.48 million activity. (NASDAQ:GILD) has "Buy" rating given on Monday, August 28 by Credit Suisse. Therefore 17% are positive. On Friday, October 2 the stock rating was downgraded by Morgan Stanley to "Equal-Weight". The stock has "Hold" rating by Oppenheimer on Thursday, December 21. The stock of NuStar GP Holdings, LLC (NYSE:NSH) has "Neutral" rating given on Friday, February 3 by Citigroup. As per Wednesday, April 12, the company rating was maintained by Credit Suisse. The stock presently has a consensus rating of "Buy" and an average price target of $85.53. The company was maintained on Wednesday, August 5 by Citigroup. RBC Capital Markets maintained it with "Buy" rating and $156.0 target in Sunday, November 5 report. Investors of record on Friday, December 15th were paid a $0.52 dividend. Its up 0.90, from 1.6 in 2017Q2. It has no change, as 47 investors sold CI shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. William Blair reaffirmed a "buy" rating on shares of Gilead Sciences in a report on Thursday, October 19th. However, the institutional investors are observed to own 79.60% of the total shares. Amundi Pioneer Asset owns 5.91M shares or 1.52% of their United States portfolio. Chemical Retail Bank accumulated 30,538 shares. Freestone Capital holds 0.09% in American International Group, Inc. Jpmorgan Chase reported 0% stake. Daiwa Sb Invs Limited invested 0.01% in Cigna Corporation (NYSE:CI). Factory Mutual Insur invested in 0.52% or 588,900 shares. 23,700 are held by Capstone Inv Advsrs Limited. Following the transaction, the insider now owns 3,070,099 shares in the company, valued at $230,656,537.87. They expect $1.67 EPS, down 36.74% or $0.97 from last year's $2.64 per share.

Other reports by Iphone Fresh

Discuss This Article